Investors Overview
PharmAust Limited will continue to pursue its strategy of consolidation of the existing businesses, and growth of the Group through each of its major operating businesses in order to:
- Reduced overheads and costs ;
- Increase market share;
- Build high-value intellectual property resources;
- Comply with TGA registration requirements
- Sponsor, register, and market all products including generics in a timely fashion, in Australia;
- Focus Epichem on further expansion of the business
©2013 PharmAust Limited (ABN 35 094 006 023)